HAP Trading’s Trillium Therapeutics Inc. TRIL Stock Holding History

HAP Trading’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-63,100	Closed	-$18K	–	3035
2021 Q3	$18K	Buy	63,100 +46,000	+269%	+$537K	﹤0.01%	1847
2021 Q2	$11K	Buy	+17,100	New	+$161K	﹤0.01%	1985
2021 Q1	–	Sell	-40,600	Closed	-$102K	–	2755
2020 Q4	$102K	Buy	+40,600	New	+$585K	﹤0.01%	1165
2020 Q3	–	Sell	-18,800	Closed	-$53K	–	2031
2020 Q2	$53K	Buy	+18,800	New	+$116K	﹤0.01%	1024

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

HAP Trading's TRIL Position: Q4 2021 in Review

HAP Trading sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 72,458 shares — an estimated $1.27M sold.

HAP Trading first reported a position in TRIL in Q3 2021 and held it in 1 quarter. The position peaked at $1.27M in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

HAP Trading reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
HAP Trading sold 72,458 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $1.27M.
HAP Trading first reported a position in Trillium Therapeutics Inc. in Q3 2021 and held it in 1 quarter.
HAP Trading's Trillium Therapeutics Inc. position peaked at $1.27M in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on HAP Trading's 13F filing for Q4 2021, filed 14 Feb 2022.